CEOArthur Costa
BS Chemical Biology, UChicago ’27Chemical biology research in the labs of Nobel laureates Jennifer Doudna and Jack Szostak. 2026 Goldwater Scholar.
Decoding disease
We’re developing SynLecs, synthetic lectins that recognize glycan features, to open new possibilities in diagnostics and biological research.
Oxum Glycosciences
Make glycan structure measurable.
Glycans are branched chains of sugars. Their structures change in cancer, autoimmune disease, and infection. Reading those changes could reveal a broader class of diagnostic signals.

SynLecs are synthetic lectins: proteins we’re engineering to recognize specific glycan structures. They provide the molecular recognition that enables our sequencing platform.

CEOChemical biology research in the labs of Nobel laureates Jennifer Doudna and Jack Szostak. 2026 Goldwater Scholar.
CTOBiomolecular engineering research in Nobel laureate Jack Szostak’s lab, with experience across startups and industry. Previously on Jane Street’s strategy and product team.
COOManagement, grant writing, and fundraising experience, with direct experience supporting founder Josh Penn.
Talk with us about research, investment, or building the next generation of glycan sequencing tools.
contact@oxumglyco.com